Anyone else remember Epitan's Epipharm unit?
Remember how that was supposed to get the company's feet wet with sales and marketing? The products that arm of the company weren't bringing in much money, but I found it intriguing when Wolgen mentioned in a recent video they don't have the sales expertise.
Maybe Epipharm's concept wasn't such a bad idea by the former CEO after all. The timing of the implementation of it may not have been right, but I found it all quite ironic given the current situation Clinuvel is in.
Anyone else remember Epitan's Epipharm unit? Remember how that...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.58 |
Change
-0.930(6.00%) |
Mkt cap ! $730.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.74 | $14.23 | $4.173M | 285.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $14.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.58 | 1486 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |